Skip to main content
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · CTXR ISIN · US17322U2078 LEI · 5493005C10W36P4KQP40 US Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2013-12-31 Regulatory Filings
Country US United States of America
Listing US CTXR

About Citius Pharmaceuticals, Inc.

https://www.citiuspharma.com/

Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).

Recent filings

Filing Released Lang Actions
NT-10K
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the registrant, Trail One, Inc., requires additional time to complete its 2013 Form 10-K annual report beyond the scheduled due date. The document does not contain the actual 10-K report or financial data but is a notification about the delay in filing the 10-K. The document length is short (3641 characters) and serves as an announcement rather than the report itself. According to the classification rules, such a notification is best classified as a Regulatory Filing (RNS) because it is a compliance document notifying the SEC of a late filing, not the actual annual report.
2013-12-31 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q3 2013
2013-09-18 English
Regulatory Filings 2013
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company, Trail One, Inc., was unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2013, by the deadline and requests additional time to file it. The document does not contain the actual financial statements or substantive financial data of the 10-Q report but is rather a notification about the delay in filing that report. According to the rules, such a notification is a Regulatory Filing (RNS) because it is a compliance document related to filing deadlines and does not contain the report itself.
2013-08-15 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a change in control of the registrant, including the sale of a significant number of shares and the appointment of a new CEO and director. This corresponds to announcements about changes in the company's board of directors or senior management. The document does not contain financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a proxy statement or voting results announcement. Therefore, the appropriate classification is Board/Management Information (MANG). The document length (5213 characters) supports it being a full report rather than a brief announcement or certification.
2013-06-10 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q2 2013
2013-05-13 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-02-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.